Geneva Pioneers Precision Psychiatry with AI and Brain Scans

Researchers at Campus Biotech aim to transform mental health treatment through personalized care and cutting-edge technology.

Apr. 11, 2026 at 9:50am

Got story updates? Submit your updates here. ›

A vibrant, neon outline of a human brain against a dark background, symbolizing the innovative approach to mental health care in Geneva.Geneva's precision psychiatry program harnesses the power of neuroscience and AI to deliver personalized, effective mental health treatments.Geneva Today

The future of mental health treatment is evolving rapidly in Geneva, where researchers and psychiatrists are combining AI, brain imaging, and personalized care to revolutionize psychiatric disorders. By using AI to analyze patient data and target specific brain regions with transcranial magnetic stimulation, the Geneva team hopes to provide more effective and efficient treatments, moving away from the traditional trial-and-error approach.

Why it matters

Current psychiatric treatments often involve lengthy and uncertain journeys, exposing patients to potential side effects from ineffective medications. The precision psychiatry approach in Geneva aims to change this by using advanced technology to tailor treatments to individual patients, reducing suffering and improving outcomes.

The details

At the heart of Geneva's precision psychiatry initiative is the collaboration between neuroscientists and psychiatrists at Campus Biotech. By integrating clinical psychiatry, neuroscience, and data science, the team is leveraging AI and brain imaging to predict the most effective treatment for each patient, whether it's stimulation, psychotherapy, medication, or a combination. The personalized neuromodulation technique, which maps each patient's brain circuits to target specific regions, is a key component of this approach.

  • Researchers have been studying the brain and its connection to mental health disorders for years.
  • The precision psychiatry initiative at Campus Biotech in Geneva is currently underway, with the goal of transforming psychiatric care.
  • The integration of AI and neuroscience at Campus Biotech is a significant step forward, happening in 2026.

The players

Campus Biotech

A hub of innovation in Geneva, where researchers and clinicians are working together to refine and test new therapies for mental health disorders.

Neuroscientists

Researchers who have been studying the brain and its connection to mental health disorders, providing crucial insights for the precision psychiatry approach.

Psychiatrists

Healthcare professionals who are collaborating with neuroscientists to integrate clinical psychiatry, neuroscience, and data science to improve mental health treatments.

Got photos? Submit your photos here. ›

What they’re saying

“We must move away from the trial-and-error approach and provide more personalized, effective treatments for our patients.”

— Dr. Emilia Rousseau, Lead Psychiatrist, Campus Biotech

“The integration of AI and neuroscience is a game-changer in the field of mental health. We're excited to see how this collaboration can transform the lives of those struggling with psychiatric disorders.”

— Dr. Luc Dupont, Director of Neuroscience Research, Campus Biotech

What’s next

Researchers at Campus Biotech plan to continue refining and testing their precision psychiatry approach, with the goal of making it a standard of care in the near future. They are also working to expand their collaboration with other healthcare institutions to share their findings and best practices.

The takeaway

Geneva's precision psychiatry initiative represents a significant step forward in the treatment of mental health disorders. By combining cutting-edge technology with personalized care, the researchers and clinicians at Campus Biotech are paving the way for a future where psychiatric treatments are more effective, efficient, and tailored to the individual, reducing suffering and improving outcomes for patients.